2016 Thyroid Cancer Update: A Review of the New American Thyroid Association Guidelines
2016 AAO-HNSF Annual Meeting &OTO EXPOSM
Keyword(s)
Thyroid cancer, Surgical management
Well-differentiated thyroid cancer frequently presents to otolaryngologists and endocrinologists and management typically involves surgical extirpation. Due to the relatively favorable prognosis that accompanies these cancers, it is critical to strike the appropriate balance between optimizing disease control while minimizing morbidities such as recurrent and superior laryngeal nerve injuries and hypoparathyroidism. After surgery, considerations for adjuvant therapy must be made and eventually surveillance will be initiated. This expert panel will provide an update on the new American Thyroid Association Guidelines focusing on work-up and management of the primary tumor and cervical lymphatics, as well as adjuvant therapy and surveillance. Following brief background presentations on these topics, salient points will be highlighted through a case-based tumor board discussion.
Description
Well-differentiated thyroid cancer frequently presents to otolaryngologists and endocrinologists and management typically involves surgical extirpation. Due to the relatively favorable prognosis that accompanies these cancers, it is critical to strike the appropriate balance between optimizing disease control while minimizing morbidities such as recurrent and superior laryngeal nerve injuries and hypoparathyroidism. After surgery, considerations for adjuvant therapy must be made and eventually surveillance will be initiated. This expert panel will provide an update on the new American Thyroid Association Guidelines focusing on work-up and management of the primary tumor and cervical lymphatics, as well as adjuvant therapy and surveillance. Following brief background presentations on these topics, salient points will be highlighted through a case-based tumor board discussion. Learning Objectives:1: Understand the appropriate work-up and upfront surgical management of locally advanced well-differentiated thyroid cancer. 2: Recognize the indications for central and lateral neck dissection in patients with well-differentiated thyroid cancer. 3: Understand indications for radioactive iodine therapy following surgery for well-differentiated thyroid cancer and be able to determine an appropriate regimen for disease surveillance following initial management. Faculty:Michael Moore, MD (AO North America(Consulting fees or honoraria (independent contractor/speakers bureau/advisory committees/review panels)): Honoraria Intuitive Surgical (Consulting fees or honoraria (independent contractor/speakers bureau/advisory committees/review panels)): Honoraria); Michael C. Singer, MD (Medtronic (Consultant/Advisory Board, Other Research Support includes receipt of drugs, supplies, equipment or other in-kind support)); Maisie Shindo, MD(No relationships todisclose); Derrick T. Lin, MD(No relationships to disclose);Scharukh Jalisi, MD(DRX UC Watertown PC (Ownership interest (stocks/stock options/excluding diversified mutual funds)): Ownership Interest includes stock, stock options, patent or other intellectual property);Kevin Brumund, MD (No relationships to disclose);Wendy Sacks, MD(No relationships to disclose).
